Pheochromocytoma
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
GLUT1CBP is also expressed in primary cultures of neurons and astrocytes, as well as in Chinese hamster ovary, 3T3-L1, Madin-Darby canine kidney, Caco-2, and pheochromocytoma-12 cell lines.
|
10198040 |
1999 |
Adrenal Gland Pheochromocytoma
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
GLUT1CBP is also expressed in primary cultures of neurons and astrocytes, as well as in Chinese hamster ovary, 3T3-L1, Madin-Darby canine kidney, Caco-2, and pheochromocytoma-12 cell lines.
|
10198040 |
1999 |
Malignant Neoplasms
|
0.060 |
Biomarker
|
group |
BEFREE |
Since other proteins, like 5T4, associate with TIP-2/GIPC and are linked with cancer, we explore the possibility that TIP-2/GIPC may be a common factor involved in the cancer process.
|
11798178 |
2002 |
Primary malignant neoplasm
|
0.050 |
Biomarker
|
group |
BEFREE |
Since other proteins, like 5T4, associate with TIP-2/GIPC and are linked with cancer, we explore the possibility that TIP-2/GIPC may be a common factor involved in the cancer process.
|
11798178 |
2002 |
Carcinogenesis
|
0.020 |
Biomarker
|
phenotype |
BEFREE |
Therefore, GIPC1, GIPC2 and GIPC3 might play key roles in carcinogenesis and embryogenesis through modulation of growth factor signaling and cell adhesion.
|
12011974 |
2002 |
Colorectal Neoplasms
|
0.010 |
AlteredExpression
|
group |
BEFREE |
This is the first report on molecular cloning of GIPC2, the second member of the GIPC gene family, which is down-regulated in human primary kidney and colorectal tumors.
|
11836570 |
2002 |
Kidney Neoplasm
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
Expression of GIPC1 mRNA was down-regulated in 12 out of 14 cases of primary kidney tumors, 10 out of 18 cases of primary colorectal tumors, 3 out of 8 cases of primary gastric cancer, 3 out of 3 cases of primary prostate cancer.
|
11956658 |
2002 |
leukemia
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
On the other hand, GIPC1 mRNA was almost undetectable in leukemia/lymphoma cell lines HL-60, Raji, and Daudi.
|
11956658 |
2002 |
Malignant neoplasm of stomach
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
GIPC1 mRNA was relatively highly expressed in gastric cancer cell lines OKAJIMA, TMK1, MKN28, MKN45, MKN74, KATO-III, pancreatic cancer cell line AsPC-1, colorectal cancer cell line SW480, and lung cancer cell line A549.
|
11956658 |
2002 |
Neoplasm Metastasis
|
0.010 |
Biomarker
|
phenotype |
BEFREE |
5T4 interacts with TIP-2/GIPC, a PDZ protein, with implications for metastasis.
|
11798178 |
2002 |
Malignant neoplasm of lung
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
GIPC1 mRNA was relatively highly expressed in gastric cancer cell lines OKAJIMA, TMK1, MKN28, MKN45, MKN74, KATO-III, pancreatic cancer cell line AsPC-1, colorectal cancer cell line SW480, and lung cancer cell line A549.
|
11956658 |
2002 |
Carcinoma of lung
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
GIPC1 mRNA was relatively highly expressed in gastric cancer cell lines OKAJIMA, TMK1, MKN28, MKN45, MKN74, KATO-III, pancreatic cancer cell line AsPC-1, colorectal cancer cell line SW480, and lung cancer cell line A549.
|
11956658 |
2002 |
Stomach Carcinoma
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
GIPC1 mRNA was relatively highly expressed in gastric cancer cell lines OKAJIMA, TMK1, MKN28, MKN45, MKN74, KATO-III, pancreatic cancer cell line AsPC-1, colorectal cancer cell line SW480, and lung cancer cell line A549.
|
11956658 |
2002 |
Primary malignant neoplasm of lung
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
GIPC1 mRNA was relatively highly expressed in gastric cancer cell lines OKAJIMA, TMK1, MKN28, MKN45, MKN74, KATO-III, pancreatic cancer cell line AsPC-1, colorectal cancer cell line SW480, and lung cancer cell line A549.
|
11956658 |
2002 |
Childhood Leukemia
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
On the other hand, GIPC1 mRNA was almost undetectable in leukemia/lymphoma cell lines HL-60, Raji, and Daudi.
|
11956658 |
2002 |
Pancreatic Neoplasm
|
0.010 |
Biomarker
|
disease |
LHGDN |
Knockdown of GIPC led to a significant inhibition of pancreatic tumor cell growth in vivo in different mouse models.
|
18314626 |
2007 |
Mammary Neoplasms
|
0.030 |
AlteredExpression
|
group |
LHGDN |
A human monoclonal autoantibody to breast cancer identifies the PDZ domain containing protein GIPC1 as a novel breast cancer-associated antigen.
|
18721486 |
2008 |
Mammary Neoplasms
|
0.030 |
AlteredExpression
|
group |
LHGDN |
Native human autoantibodies targeting GIPC1 identify differential expression in malignant tumors of the breast and ovary.
|
18721484 |
2008 |
Neoplasms
|
0.030 |
Biomarker
|
group |
BEFREE |
Additionally, a cell-permeable GIPC-PDZ inhibitor was able to block tumor growth significantly without showing toxicity in a mouse model.
|
19509165 |
2009 |
Malignant neoplasm of breast
|
0.020 |
AlteredExpression
|
disease |
BEFREE |
GIPC/Synectin has been shown to be overexpressed in pancreatic and breast cancer.
|
19509165 |
2009 |
Pancreatic carcinoma
|
0.020 |
Biomarker
|
disease |
BEFREE |
The in vivo effects of GIPC/Synectin knockdown were studied after lentiviral transduction of luciferase-expressing pancreatic cancer cells with short hairpin RNA against GIPC/Synectin.
|
19509165 |
2009 |
Malignant neoplasm of pancreas
|
0.020 |
Biomarker
|
disease |
BEFREE |
The in vivo effects of GIPC/Synectin knockdown were studied after lentiviral transduction of luciferase-expressing pancreatic cancer cells with short hairpin RNA against GIPC/Synectin.
|
19509165 |
2009 |
Breast Carcinoma
|
0.020 |
AlteredExpression
|
disease |
BEFREE |
GIPC/Synectin has been shown to be overexpressed in pancreatic and breast cancer.
|
19509165 |
2009 |
Adenocarcinoma of pancreas
|
0.010 |
Biomarker
|
disease |
BEFREE |
Knockdown of GIPC/Synectin led to a significant inhibition of pancreatic adenocarcinoma growth in an orthotopic mouse model.
|
19509165 |
2009 |
Malignant Neoplasms
|
0.060 |
AlteredExpression
|
group |
BEFREE |
GIPC1 is highly expressed in a number of human malignancies, including breast, ovarian, gastric, and pancreatic cancers.
|
21209904 |
2010 |